: The AMEDEO Literature Guide

Home

Fast Track

My Amedeo

FAQ

About

Flying Publisher

	Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

HIV Infection

Free Subscription

Articles published in J Acquir Immune Defic Syndr
Retrieve available abstracts of 441 articles:
HTML format
Text format

Single Articles

February 2012

SARAVANAN S , Madhavan V, Solomon SS, Kantor R, et al
Reverse Transcriptase Substitution at Codons 208 and 228 Among Treatment-Experienced HIV-1 Subtype-C-Infected Indian Patients Is Strongly Associated With Thymidine Analogue Mutations.
J Acquir Immune Defic Syndr. 2012;59:e26-7.
PubMed Text format Related articles

DAMAS JK , Baekken M, Ueland T, Manner IW, et al
Serum Levels of Neutrophil Gelatinase-Associated Lipocalin Are Associated With Microalbuminuria in HIV-Infected Patients.
J Acquir Immune Defic Syndr. 2012;59:e24-e25.
PubMed Text format Related articles

DE LUCA A , Nasi M, Di Giambenedetto S, Cozzi-Lepri A, et al
Mitochondrial DNA Haplogroups and Incidence of Lipodystrophy in HIV-Infected Patients on Long-Term Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2012;59:113-20.
PubMed Text format Related articles Abstract available

January 2012

HORBERG MA , Bartemeier Hurley L, James Towner W, Allerton MW, et al
Determination of Optimized Multidisciplinary Care Team for Maximal Antiretroviral Therapy Adherence.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

DURACINSKY M , Lalanne C, Le Coeur S, Herrmann S, et al
Psychometric validation of the PROQOL-HIV questionnaire, a new health-related quality of life instrument specific to HIV disease.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

KERR J , Stephens T, Gibson JJ, Duffus WA, et al
Risk Factors Associated with Inpatient Hospital Utilization in HIV-positive Individuals and Relationship to HIV Care Engagement.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

FREGONESE F , Collins IJ, Jourdain G, Lecoeur S, et al
Predictors of 5-years mortality in HIV-infected adults starting highly active antiretroviral therapy (HAART) in Thailand.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

WADLEY AL , Lombard Z, Cherry CL, Price P, et al
Analysis of a previously identified 'pain protective' haplotype and individual polymorphisms in the GCH1 gene in Africans with HIV-associated sensory neuropathy: a genetic association study.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

FAGARD C , Colin C, Charpentier C, Rami A, et al
Long-term Efficacy and Safety of Raltegravir, Etravirine, and Darunavir/Ritonavir in Treatment-Experienced Patients: Week 96 Results from the ANRS 139 TRIO Trial.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

O'CLEIRGH C , Safren SA, Mayer KH
The Pervasive Effects of Childhood Sexual Abuse: Challenges for Improving HIV Prevention and Treatment Interventions.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles

PAI NP , Shivkumar S, Cajas JM
Does Genetic Diversity of HIV-1 Non-B Subtypes Differentially Impact Disease Progression in Treatment-Naive HIV-1 Infected Individuals? : A Systematic Review of Evidence: 1996-2010.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

ANCES BM , Ortega M, Vaida F, Heaps J, et al
Independent Effects of HIV, Aging, and HAART on Brain Volumetric Measures.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

CHUN-HAI FUNG I , Gambhir M, van Sighem A, de Wolf F, et al
The clinical interpretation of viral blips in HIV patients receiving antiviral treatment: are we ready to infer poor adherence?
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

WARE NC , Wyatt MA, Haberer JE, Baeten JM, et al
What's Love Got to Do With It? Explaining Adherence to Oral Antiretroviral Pre-exposure Prophylaxis (PrEP) for HIV Serodiscordant Couples.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

MAYER KH , Mimiaga MJ, Gelman M, Grasso C, et al
RALTEGRAVIR, TENOFOVIR DF, AND EMTRICITABINE FOR POST-EXPOSURE PROPHYLAXIS TO PREVENT THE SEXUAL TRANSMISSION OF HIV: SAFETY, TOLERABILITY AND ADHERENCE.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

HALL HI , Gray KM, Tang T, Li J, et al
Retention in Care of Adults and Adolescents living with HIV in 13 U.S. Areas.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

PACANOWSKI J , Lacombe K, Campa P, Dabrowska M, et al
Plasma HIV-RNA is the key determinant of long-term antibody persistence following Yellow fever immunization in a cohort of 364 HIV-infected patients.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

ABIMBOLA TO , Marston BJ, Date AA, Blandford JM, et al
Cost-effectiveness of Tuberculosis Diagnostic Strategies to Reduce Early Mortality among Persons with Advanced HIV Infection Initiating Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

KOENIG SP , Rodriguez LA, Bartholomew C, Edwards A, et al
Long-Term Antiretroviral Treatment Outcomes in Seven Countries in the Caribbean.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

CARD CM , Keynan Y, Lajoie J, Bell CP, et al
HIV-controllers are distinguished by chemokine expression profile and HIV-specific T cell proliferative potential.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

TABORDA NA , Catano JC, Delgado JC, Rugeles MT, et al
Higher SLPI expression, lower immune activation and increased frequency of immune cells in a cohort of Colombian HIV-1 controllers.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

ABIMBOLA TO , Marston BJ
The cost-effectiveness of cotrimoxazole in people with advanced HIV infection initiating antiretroviral therapy in sub-Saharan Africa.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

BERRY SA , Fleishman JA, Moore RD, Gebo KA, et al
TRENDS IN REASONS FOR HOSPITALIZATION IN A MULTISITE UNITED STATES COHORT OF PERSONS LIVING WITH HIV, 2001 - 2008.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

KAYIBANDA JF , Bitera R, Alary M
Violence towards women, men's sexual risk factors and HIV infection among women: Findings from a national household survey in Rwanda.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

FRENCH CE , Cortina-Borja M, Thorne C, Tookey PA, et al
Incidence, patterns, and predictors of repeat pregnancies among HIV-infected women in the United Kingdom and Ireland, 1990-2009.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

DE LUCA A , Nasi M, Di Giambenedetto S, Cozzi-Lepri A, et al
Mitochondrial DNA haplogroups and incidence of lipodystrophy in HIV-infected patients on long-term antiretroviral therapy.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

PRICE M , Rida W, Mwangome M, Mutua G, et al
Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

PONTILLO A , Oshiro TM, Girardelli M, Kamada AJ, et al
Polymorphisms in inflammasome' genes and susceptibility to HIV-1 infection.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

CULSHAW A , Dong T, Rowland-Jones S
A two amino acid shift in position leads to a substantial difference in the pattern of processing of two HIV-1 epitopes.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

BEST BM , Letendre SL, Koopmans P, Rossi SS, et al
LOW CSF CONCENTRATIONS OF THE NUCLEOTIDE HIV REVERSE TRANSCRIPTASE INHIBITOR, TENOFOVIR.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

FUMAZ CR , Munoz-Moreno JA, Ferrer MJ, Gonzalez-Garcia M, et al
Emotional Impact of Premature Aging Symptoms in Long-Term Treated HIV-Infected Subjects.
J Acquir Immune Defic Syndr. 2012;59:e5-8.
PubMed Text format Related articles

SUNGKANUPARPH S , Kiertiburanakul S, Sukasem C, Chantratita W, et al
Discrepancies Between WHO 2009 and IAS-USA 2009 Lists for Determining the Rate of Transmitted HIV-1 Drug Resistance: A Prospective Study.
J Acquir Immune Defic Syndr. 2012;59:e3-5.
PubMed Text format Related articles

IZADI N , Goetz MB, Graber CJ
Inverse Correlation of Initial CD8 Lymphocyte Count and CD4 Lymphocyte Response to Combination Antiretroviral Therapy in Treatment-Naive HIV-Infected Patients.
J Acquir Immune Defic Syndr. 2012;59:e1-3.
PubMed Text format Related articles

BURGOS J , Penaranda M, Payeras A, Villoslada A, et al
Invasive Pneumococcal Disease in HIV-Infected Adults: Clinical Changes After the Introduction of the Pneumococcal Conjugate Vaccine in Children.
J Acquir Immune Defic Syndr. 2012;59:31-8.
PubMed Text format Related articles Abstract available

HERBST JH , Glassman M, Carey JW, Painter TM, et al
Operational Research to Improve HIV Prevention in the United States.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

ALAMO ST , Colebunders R, Ouma J, Sunday P, et al
Socio-economic support reduces non-retention in a comprehensive, community-based antiretroviral therapy program in Uganda.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

SCHNEIDER MF , Margolick JB, Jacobson LP, Reddy S, et al
Improved Estimation of the Distribution of Suppressed Plasma HIV-1 RNA in Men Receiving Effective Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

AIZIRE J , McConnell MS, Mudiope P, Mubiru M, et al
Kinetics of nevirapine and its impact on HIV-1 RNA levels in maternal plasma and breast milk over time after perinatal single dose nevirapine.
J Acquir Immune Defic Syndr. 2012.
PubMed Text format Related articles Abstract available

December 2011

DURACINSKY M , Herrmann S, Berzins B, Armstrong AR, et al
The development of PROQOL-HIV: An international instrument to assess the health-related quality of life of persons living with HIV/AIDS.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

SETHI G
Uptake and outcome of combination antiretroviral therapy (cART) in men who have sex with men (MSM) according to ethnic group: the UK CHIC Study.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

ALAM N , Cortina-Borja M, Goetghebuer T, Marczynska M, et al
Body fat abnormality in HIV-infected children and adolescents living in Europe: prevalence and risk factors Fat abnormality in children.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

NAIK B , Kumar A, Lal K, Doddamani S, et al
HIV prevalence among persons suspected of tuberculosis: Policy implications for India.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

JOHNSON LF , Stinson K, Newell ML, Bland RM, et al
The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

SCOTT-SHELDON LA , Huedo-Medina TB, Warren MR, Johnson BT, et al
Efficacy of behavioral interventions to increase condom use and reduce sexually transmitted infections: a meta-analysis, 1991 to 2010.
J Acquir Immune Defic Syndr. 2011;58:489-98.
PubMed Text format Related articles Abstract available

MONROE AK , Chander G, Moore RD
Control of Medical Comorbidities in Individuals With HIV.
J Acquir Immune Defic Syndr. 2011;58:458-62.
PubMed Text format Related articles Abstract available

RAMKISSOON A , Beksinska M, Searle C, Govender T, et al
HIV Counseling and Testing in an Urban Reproductive Primary Health Clinic in South Africa: Gender Differences Among Clients.
J Acquir Immune Defic Syndr. 2011;58:e138-40.
PubMed Text format Related articles

FRENTZ D , van de Vijver DA, Boucher CA, Albert J, et al
Estimates of HIV Transmitted Drug Resistance Can be Inflated Due to Natural Sequence Polymorphisms.
J Acquir Immune Defic Syndr. 2011;58:e135-7.
PubMed Text format Related articles

HILL A , Khoo S, Boffito M, Back D, et al
Should We Switch to a 50-mg Boosting Dose of Ritonavir for Selected Protease Inhibitors?
J Acquir Immune Defic Syndr. 2011;58:e137-8.
PubMed Text format Related articles

SHAH SK , Dawson L, Dixon DO, Lie RK, et al
Should sponsors and DSMBs share interim results across trials?
J Acquir Immune Defic Syndr. 2011;58:433-5.
PubMed Text format Related articles

NGLAZI MD , van Schaik N, Kranzer K, Lawn SD, et al
An incentivized HIV counseling and testing program targeting hard-to-reach unemployed men in Cape Town, South Africa.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MANSERGH G , Valdiserri RO, Yakovchenko V, Koh H, et al
Aligning Resources to Fight HIV/AIDS in the United States: Funding to States through the U.S. Department of Health and Human Services.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

BUCHER HC , Richter W, Glass TR, Magenta L, et al
Small dense lipoproteins, apolipoprotein B and risk of coronary events in HIV-infected patients on antiretroviral therapy: The Swiss HIV Cohort Study.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

RICH M , Miller AC, Niyigena P, Franke MF, et al
Excellent clinical outcomes and high retention in care among adults in a community-based HIV treatment program in rural Rwanda.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MAYNE E , Funderburg NT, Sieg SF, Asaad R, et al
Increased platelet and microparticle activation in HIV infection: upregulation of P-selectin and tissue factor expression.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

WANYAMA JN , Castelnuovo B, Robertson G, Newell K, et al
A Randomized Controlled Trial to Evaluate the Effectiveness of a Board Game on Patients' Knowledge Uptake of HIV and Sexually Transmitted Diseases at the Infectious Diseases Institute, Kampala, Uganda.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

RUSCONI S
Investigators Involvement in the Care of HIV-Infected Individuals: The Experience in Recent Clinical Trials.
J Acquir Immune Defic Syndr. 2011;58:e118-9.
PubMed Text format Related articles

CLARKE RE , Campbell LJ, Couchman L, Moniz CF, et al
Contribution of Vitamin D2 to Total Vitamin D in HIV-Positive Patients.
J Acquir Immune Defic Syndr. 2011;58:e117-8.
PubMed Text format Related articles

AMMASSARI A , Trotta MP, Shalev N, Tettoni MC, et al
Timed Short Messaging Service Improves Adherence and Virological Outcomes in HIV-1-Infected Patients With Suboptimal Adherence to Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2011;58:e113-e115.
PubMed Text format Related articles

VERGARA-RODRIGUEZ PT , Jo Tozzi M, Botsko M, Nandi V, et al
Reply to Letter "Additional Explanation for Lack of Pharmacodynamic Interaction Between Atazanavir and Buprenorphine Reported by Vergara-Rodriquez et al"
J Acquir Immune Defic Syndr. 2011;58:e112-e113.
PubMed Text format Related articles

HEIDARI S , Mofenson LM, Hobbs CV, Cotton MF, et al
Unresolved Antiretroviral Treatment Management Issues in HIV-Infected Children.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

BRUCE RD
Additional explanation for lack of pharmacodynamic interaction between atazanavir and buprenorphine reported by vergara-rodriquez et Al.
J Acquir Immune Defic Syndr. 2011;58:e112.
PubMed Text format Related articles

November 2011

STREHLAU R , Coovadia A, Abrams EJ, Martens L, et al
Lipid Profiles in Young HIV-infected Children Initiating and Changing Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MARKS DK , Goldstone SE
Electrocautery Ablation of High-Grade Anal Squamous Intraepithelial Lesions in HIV-Negative and HIV-Positive Men who have sex with Men.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

CARRIERI MP , Wolfe D, Roux P
Reconceptualizing research on HIV treatment outcomes among criminalized groups.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles

MILLOY MJ , Kerr T, Buxton J, Rhodes T, et al
Social and environmental predictors of plasma HIV RNA rebound among injection drug users treated with antiretroviral therapy.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

LUCA D , Marazzi MC, Mancinelli S, Ceffa S, et al
Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in Sub-Saharan Africa. Andrea.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

RAMOGOLA-MASIRE D , de Klerk R, Monare B, Ratshaa B, et al
Cervical Cancer Prevention in HIV-infected Women Using the ''See and Treat'' Approach in Botswana.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MURO EP , Fillekes Q, Kisanga ER, L'homme R, et al
Intrapartum single-dose carbamazepine reduces nevirapine levels faster and may decrease resistance after a single dose of nevirapine for perinatal HIV prevention.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

GREIG J , O'brien D, Ford N, Spelman T, et al
Reduced mortality and loss to follow-up in integrated compared with vertical programmes providing antiretroviral treatment in sub-Saharan Africa.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

TUKEI VJ , Asiimwe A, Maganda A, Atugonza R, et al
SAFETY AND TOLERABILITY OF ANTIRETROVIRAL THERAPY AMONG HIV-INFECTED CHILDREN AND ADOLESCENTS IN UGANDA.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

DOOLEY KE , Park JG, Swindells S, Allen R, et al
Safety, tolerability, and pharmacokinetic interactions of the antituberculous agent TMC207 (bedaquiline) with efavirenz in healthy volunteers: AIDS Clinical Trials Group study A5267.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

PENCE BW , Mugavero MJ, Carter TJ, Leserman J, et al
Childhood trauma and health outcomes in HIV-infected patients: An exploration of causal pathways.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MAHESWARAN H , Thulare H, Stanistreet D, Tanser F, et al
Starting a home and mobile HIV testing service in a rural area of South Africa.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

SERRANO-VILLAR S , Estrada V, Gomez-Garre D, Avila M, et al
Incipient Renal Impairment as a Predictor of Subclinical Atherosclerosis in HIV Infected Patients.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

KIM MH , Cox C, Dave A, Draper HR, et al
Prompt initiation of ART with therapeutic food is associated with improved outcomes in HIV infected Malawian children with malnutrition.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

NEOGI U , Sahoo PN, Arumugam K, Sonnerborg A, et al
Higher prevalence of predicted X4-tropic strains in perinatally-infected older children with HIV-1 subtype C in India.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

CRYSTAL H , Kleyman I, Anastos K, Lazar J, et al
Effects of hepatitis C and HIV on cognition in women: Data from the Women's Interagency HIV Study.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

LOPEZ-MARTINEZ A , O Brien NM, Caro-Vega Y, Crabtree-Ramirez B, et al
Different baseline characteristics and different outcomes of HIV infected patients receiving HAART through clinical trials compared to routine care in Mexico.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

GANDHI RT , Coombs RW, Chan ES, Bosch RJ, et al
No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1-infected Patients Receiving Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

SWEET T , Welles S
ASSOCIATIONS OF SEXUAL IDENTITY OR SAME-SEX BEHAVIORS WITH HISTORY OF CHILDHOOD SEXUAL ABUSEAND HIV/STI RISK IN THE UNITED STATES.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

CRESSEY TR , Stek A, Capparelli E, Bowonwatanuwong C, et al
Efavirenz Pharmacokinetics during the Third Trimester of Pregnancy and Postpartum.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

NAKAGAWA F
Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug experienced people with HIV in Europe.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

JACOBSON DL , Li H, Andres Houseman E, Aldrovandi GM, et al
Using cluster heat maps to investigate relationships between body composition and laboratory measurements in HIV-infected and HIV-uninfected children and young adults.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MEDITZ AL , Moreau KL, Mawhinney S, Gozansky WS, et al
CCR5 Expression is Elevated on Endocervical CD4+ T-Cells in Healthy Postmenopausal Women.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

NSANZIMANA S , Ruton H, Lowrance DW, Cishahayo S, et al
Cell Phone- and Internet-based Monitoring and Evaluation of the National Antiretroviral Treatment Program during Rapid Scale-up in Rwanda: TRACnet, 2004--2010.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

RIMSKY L , Vingerhoets J, Van Eygen V, Eron J, et al
Genotypic and phenotypic characterization of HIV-1 isolates obtained from patients on rilpivirine therapy experiencing virologic failure in the phase 3 ECHO and THRIVE studies: 48-week analysis.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles

MOSCICKI AB , Kaul R, Yifei, Scott ME, et al
Measurement of mucosal biomarkers in a phase 1 trial of intravaginal 3% SPL 7013 gel (VivaGel(R)) to assess expanded safety.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

KROWN SE , Roy D, Lee JY, Dezube BJ, et al
Rapamycin with Antiretroviral Therapy in AIDS-Associated Kaposi Sarcoma: An AIDS Malignancy Consortium Study.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

HUTCHINSON AB , Farnham PG, Duffy N, Wolitski RJ, et al
Return on Public Health Investment: CDC's Expanded HIV Testing Initiative.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

CLIFFORD DB , Simpson DM, Brown S, Moyle G, et al
A Randomized, Double-Blind, Controlled Study of NGX-4010, a Capsaicin 8% Dermal Patch, for the Treatment of Painful HIV-associated Distal Sensory Polyneuropathy.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

TIU CT , Lin YS, Pagala M, Ghitan M, et al
Antibody Response to Inactivated Influenza A (H1N1) 2009 Monovalent Vaccine in Patients With and Without HIV.
J Acquir Immune Defic Syndr. 2011;58:e99-e102.
PubMed Text format Related articles

LUETKEMEYER AF , Charlebois ED, Hare CB, Black D, et al
Resistance Patterns and Response to Entecavir Intensification Among HIV-HBV-Coinfected Adults With Persistent HBV Viremia.
J Acquir Immune Defic Syndr. 2011;58:e96-9.
PubMed Text format Related articles

UBEDA AC , Moreno JS, Williams F, Gorgolas M, et al
Efficacy and Safety of Nevirapine + Kivexa (Abacavir/Lamivudine) as a Simplification Strategy for HIV Patients With Undetectable Viral Load.
J Acquir Immune Defic Syndr. 2011;58:e95-6.
PubMed Text format Related articles

October 2011

BASSETT IV , Chetty S, Wang B, Mazibuko M, et al
Loss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South Africa.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

SCHERRER AU , von Wyl V, Gotte M, Klimkait T, et al
Polymorphic mutations associated with the emergence of the multi-nucleoside/tide resistance mutations 69 insertion and Q151M.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

RAMAUTARSING RA , van der Lugt J, Gorowara M, Wongsabut J, et al
Neither branded nor generic lopinavir/ritonavir produces adequate lopinavir concentrations at a reduced dose of 200/50 mg BID.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

LEWDEN C , Gabillard D, Minga A, Ekouevi DK, et al
CD4-specific mortality rates among HIV-infected adults with high CD4 counts and no antiretroviral treatment in West Africa.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

IVY W 3RD , Dominguez KL, Rakhmanina NY, Iuliano AD, et al
Premastication as a route of pediatric HIV transmission: Case-control and cross-sectional investigations: Pediatric HIV risk via Premastication.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

YODER RB , Nyandiko WM, Vreeman RC, Ayaya SO, et al
Long-term impact of the Kenya post-election crisis on clinic attendance and medication adherence for HIV-infected children in western Kenya.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MAYER KH , Ducharme R, Zaller N, Chan PA, et al
UNPROTECTED SEX, UNDERESTIMATED RISK, UNDIAGNOSED HIV AND SEXUALLY TRANSMITTED DISEASES AMONG MEN WHO HAVE SEX WITH MEN ACCESSING TESTING SERVICES IN A NEW ENGLAND BATHHOUSE.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

KULKARNI R , Babaoglu K, Lansdon EB, Rimsky L, et al
The HIV-1 Reverse Transcriptase M184I Mutation Enhances the E138K-associated Resistance to Rilpivirine and Decreases Viral Fitness.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

PEDRANA AE , Hellard ME, Wilson K, Guy R, et al
High rates of undiagnosed HIV infections in a community sample of gay men in Melbourne, Australia.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

ALBINI L , Cesana BM, Motta D, Foca E, et al
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

YAN H , Yang H, Zhao J, Wei C, et al
Long-chain peer referral of men who have sex with men: A novel approach to establish and maintain a cohort to measure HIV incidence, Nanjing, China.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

KOPPENHAVER RT , Sorensen SW, Farnham PG, Sansom SL, et al
The cost-effectiveness of pre-exposure prophylaxis in men who have sex with men in the United States: an epidemic model.
J Acquir Immune Defic Syndr. 2011;58:e51-2.
PubMed Text format Related articles

COGHLAN B , Millan J, Malau C, Kaldor J, et al
The HIV Epidemic in Papua New Guinea.
J Acquir Immune Defic Syndr. 2011;58:e48-51.
PubMed Text format Related articles

IMAZ A , Llibre JM, Ribera E, Clotet B, et al
The Role of Inactive Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Salvage Therapy for Drug-Resistant HIV-1 Infection in the Era of New Classes and New Generation Antiretrovirals.
J Acquir Immune Defic Syndr. 2011;58:e46-8.
PubMed Text format Related articles

KFUTWAH AK , Tejiokem MC, Ateba FN, Ndongo JA, et al
Seronegativation in Early Treated HIV-Infected Infants: Frequency and Potential Implications on Care and Follow-up in a Resource-Limited Country.
J Acquir Immune Defic Syndr. 2011;58:e43-e46.
PubMed Text format Related articles

SIDIQUE N , Kohli A, Shivakumar B, Migueles S, et al
HIV/HCV-Coinfected Natural Viral Suppressors Have Better Virologic Responses to PEG-IFN and Ribavirin Than ARV-Treated HIV/HCV Patients.
J Acquir Immune Defic Syndr. 2011;58:e38-40.
PubMed Text format Related articles

September 2011

LUCZKOWIAK J , Martinez-Prats L, Sierra O, Fiorante S, et al
Lack of the detection of XMRV or Polytropic MLV-related sequences in blood cells from HIV-1 infected patients in Spain.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

CONESA-BOTELLA A , Loembe MM, Manabe YC, Worodria W, et al
Urinary lipoarabinomannan as predictor for the tuberculosis immune reconstitution inflammatory syndrome.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

KOSGEI RJ , Lubano KM, Shen C, Wools-Kaloustian KK, et al
Impact of integrated family planning and HIV care services on contraceptive use and pregnancy outcomes: a retrospective cohort study.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

NDASE P , Celum C, Thomas K, Donnell D, et al
Outside Sexual Partnerships and Risk of HIV Acquisition for HIV Uninfected Partners in African HIV Serodiscordant Partnerships.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MCINTYRE JA
Can devices for adult male circumcision help bridge the implementation gap for HIV prevention services?
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

BLANCO NB , Probst A, Da Costa VW, Giulieri S, et al
Impact of a Nurse Vaccination Program on Hepatitis B Immunity in a Swiss HIV Clinic.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

LICHTERFELD M , Gandhi RT, Simmons RP, Flynn T, et al
Induction of Strong HIV-1-specific CD4+ T Cell Responses using an HIV-1 gp120/NefTat Vaccine adjuvanted with AS02A in ARV Treated HIV-1-Infected Individuals.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MCCONNELL MJ , Mier-Mota J, Flor-Parra F, Martinez-Fernandez FJ, et al
Improved viral suppression after treatment optimization in HIV-infected patients with persistent low-level viremia.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

SAHASTRABUDDHE S , Gupta A, Stuart E, Godbole S, et al
Sexually Transmitted Infections and Risk Behaviors Among Transgender persons (Hijras) of Pune, India.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

STAEHELIN C , Keiser O, Calmy A, Weber R, et al
Longer term clinical and virological outcome of Sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MUGAVERO MJ , Amico KR, Westfall AO, Crane HM, et al
Early Retention in HIV Care and Viral Load Suppression: Implications for a Test and Treat Approach to HIV Prevention.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

LOUISSAINT NA , Nimmagadda S, Fuchs EJ, Bakshi RP, et al
Distribution of Cell-free and Cell-associated HIV surrogates in the Colon Following Simulated Receptive Anal Intercourse in Men who Have Sex with Men.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

AL L , Fb L, Ek S, Jrr M, et al
Prevalence of low estimated glomerular filtration rate, proteinuria and associated risk factors among HIV-infected black patients using cockroft-gault and modification of diet in renal disease study equations.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

FILLEKES Q , Natukunda E, Balungi J, Kendall L, et al
Pediatric under-dosing of efavirenz: a pharmacokinetic study in Uganda.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

NJ L , D E, Dj B, A O, et al
IFNa 874A>T genotype is associated with higher CCR5 expression in peripheral blood mononuclear cells from HIV+ patients.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

JACKSON A , Watson V, Back D, Khoo S, et al
Plasma and intracellular pharmacokinetics of darunavir/ritonavir once daily and raltegravir once and twice daily in HIV-infected individuals.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

LI M , Patton DL, Cosgrove-Sweeney Y, Ratner D, et al
Incorporation of the HIV-1 microbicide cyanovirin-N in a food product.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

JOHNSON MO , Dilworth SE, Stephens E, Lum PJ, et al
Expectancy and readiness-based predictors of treatment uptake among the urban poor living with HIV.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

BITEGA JP , Ngeruka ML, Hategekimana T, Asiimwe A, et al
Safety and Efficacy of the PrePex Device for Rapid Scale up of Male Circumcision for HIV Prevention in Resource-Limited Settings.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MOFENSON LM
Editorial: Prevention of Mother-to-Child HIV-1 Transmission - Why We Still Need a Preventive HIV Immunization Strategy.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles

MAUGHAN-BROWN BG , Venkataramani AS, Nattrass N, Seekings J, et al
A cut above the rest: Traditional Male Circumcision and HIV Risk Among Xhosa men in Cape Town, South Africa.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

ALASSANE DP , Geraldine D, Aziz CA, Pierre NB, et al
Multi-site evaluation of a point-of-care instrument for CD4+ T cell enumeration using venous and finger prick blood: the PIMA CD4.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

THOMAS JC , Curtis S, Smith JB
The broader context of implementation science.
J Acquir Immune Defic Syndr. 2011;58:e19-21.
PubMed Text format Related articles

FATTI G , Grimwood A, Mothibi E, Shea J, et al
The effect of patient load on antiretroviral treatment programmatic outcomes at primary health care facilities in South Africa: a multicohort study.
J Acquir Immune Defic Syndr. 2011;58:e17-9.
PubMed Text format Related articles

August 2011

COHN J , Holtzman D, Baker B
Efficiencies in AIDS Programming: The Rhetoric and the Realities.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

WHITE DA , Sadoun T, Tran T, Alter HJ, et al
Increased Acceptance Rates of HIV Screening Using Opt-Out Consent Methods in an Urban Emergency Department.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

RALLON NI , Lopez M, Lozano S, Sempere-Ortells JM, et al
Longitudinal assessment of Interleukin 7 plasma levels in HIV-infected patients in the absence of and under antiretroviral therapy.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

HOFFMANN CJ , Katherine FL, Victoria J, Salome C, et al
Changing predictors of mortality over time from cART start: implications for care.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

TALAL AH , Liu RC, Zeremski M, Dimova R, et al
Randomized Trial Comparing Dose Reduction and Growth Factor Supplementation for Management of Hematological Side Effects in HIV/HCV Patients Receiving Pegylated-Interferon and Ribavirin.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

SARAVANAN S , Madhavan V, Balakrishnan P, Solomon SS, et al
HIV-1 Reverse Transcriptase Nucleotide Substitutions in Subtype C Infected Drug Naive and Treatment Experienced Patients in South India.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

BEST BM , Capparelli EV, Diep H, Rossi SS, et al
Pharmacokinetics of Lopinavir/Ritonavir Crushed versus Whole Tablets in Children.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

NEUKAM K , Rivero-Juarez A, Caruz A, Lello FD, et al
Influence of the combination of low-density lipoprotein receptor and interleukin 28B genotypes on lipid plasma levels in HIV/hepatitis C-coinfected patients.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles

GONZALEZ JS , Batchelder AW, Psaros C, Safren SA, et al
Depression and HIV/AIDS Treatment Nonadherence: A Review and Meta-analysis.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

D CL , Phd OM, Mark B, Phd GF, et al
Transactional Sex amongst AIDS-orphaned and AIDS-Affected Adolescents Predicted by Abuse and Extreme Poverty.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

VERMUND SH
Modeling interventions to assess HIV epidemic impact in Africa.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles

BOUAZZA N , Urien S, Hirt D, Frange P, et al
Population Pharmacokinetics of Tenofovir in HIV-1 Infected Pediatric Patients.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MOORE DM , Yiannoutsos CT, Musick BS, Tappero J, et al
Determinants of early and late mortality among HIV-infected individuals receiving home-based antiretroviral therapy in rural Uganda.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MUGAVERO MJ , May M, Ribaudo HJ, Gulick RM, et al
Comparative Effectiveness of Initial Antiretroviral Therapy Regimens: ACTG 5095 and 5142 Clinical Trials Relative to ART-CC Cohort Study.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

FAAL M , Naidoo N, Glencross DK, Venter WD, et al
Providing Immediate CD4 Count Results at HIV Testing Improves ART Initiation.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

O'CONNOR C
Loss to follow-up of stable antiretroviral therapy patients in a decentralized down referral model of care in Johannesburg, South Africa.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MEI J , Kennedy M, Linley L, Hanson D, et al
Standardization and Monitoring of Laboratory Performance and Quality Assurance by Use of the Less-Sensitive HIV Incidence Assay: Seven Years of Results.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

PATHELA P , Braunstein SL, Schillinger JA, Shepard C, et al
Men Who Have Sex With Men Have a 140-Fold Higher Risk for Newly Diagnosed HIV and Syphilis Compared With Heterosexual Men in New York City.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

BOCOUR A , Renaud TC, Wong MR, Udeagu CC, et al
Differences in risk behaviors and partnership patterns between younger and older men who have sex with men in New York City (NYC).
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

ZABLOTSKA IB , Prestage G, Holt M, Poynten M, et al
Australian gay men who have taken non-occupational post-exposure prophylaxis for HIV (PEP) are in need of effective HIV prevention methods.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

CHI BH , Mwango A, Giganti MJ, Sikazwe I, et al
Comparative outcomes of tenofovir- and zidovudine-based antiretroviral therapy regimens in Lusaka, Zambia.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

ALUISIO A , Richardson BA, Bosire R, John-Stewart G, et al
Reply to "Male Involvement' in Women and Children's HIV Prevention: Challenges in Definition and Interpretation".
J Acquir Immune Defic Syndr. 2011;57:e116-7.
PubMed Text format Related articles

MONTGOMERY E , van der Straten A, Torjesen K
"Male Involvement" in Women and Children's HIV Prevention: Challenges in Definition and Interpretation.
J Acquir Immune Defic Syndr. 2011;57:e114-6.
PubMed Text format Related articles

MENA A , Meijide H, Vazquez P, Castro A, et al
HIV Increases Mean Platelet Volume During Asymptomatic HIV Infection in Treatment-Naive Patients.
J Acquir Immune Defic Syndr. 2011;57:e112-3.
PubMed Text format Related articles

GOVINDASAMY D , van Schaik N, Kranzer K, Wood R, et al
Linkage to HIV Care from a Mobile Testing Unit in South Africa by Different CD4 Count Strata.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

RYSCAVAGE PA , Anderson EJ, Sutton SH, Reddy S, et al
Clinical Outcomes of Adolescents and Young Adults in Adult HIV Care.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

F C , A S F, P I, X Y, et al
Natural Killer cell activation distinguishes M. tuberculosis-mediated Immune reconstitution syndrome (IRIS) from chronic HIV and HIV-MTB co-infection.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

TORRONE EA , Bertolli JM, Li J, Sweeney PA, et al
Increased HIV and Primary and Secondary Syphilis Diagnoses among Young Men- United States, 2004-2008.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

VESCINI F , Cozzi-Lepri A, Borderi M, Re MC, et al
Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

GUTHRIE BL , Choi RY, Liu AY, Mackelprang RD, et al
Barriers to Antiretroviral Initiation in HIV-1-Discordant Couples.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

ONYANGO-MAKUMBI C , Omer SB, Mubiru M, Med Stat D, et al
Safety and Efficacy of HIV Hyperimmune Globulin (HIVIGLOB) for Prevention of Mother-to-Child HIV Transmission in HIV-1 infected Pregnant Women and their Infants in Kampala, Uganda (HIVIGLOB/NVP STUDY).
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

PEDROSO C , Netto EM, Weyll N, Brites C, et al
Coinfection by HIV-1 and Human Lymphotropic Virus Type 1 in Brazilian Children Is Strongly Associated With a Shorter Survival Time.
J Acquir Immune Defic Syndr. 2011;57 Suppl 3:S208-11.
PubMed Text format Related articles Abstract available

BAHIA F , Novais V, Evans J, Le Marchand C, et al
The Impact of Human T-Cell Lymphotropic Virus I Infection on Clinical and Immunologic Outcomes in Patients Coinfected With HIV and Hepatitis C Virus.
J Acquir Immune Defic Syndr. 2011;57 Suppl 3:S202-7.
PubMed Text format Related articles Abstract available

PESSOA LS , Valadao AL, Abreu CM, Calazans AR, et al
Genotypic Analysis of the gp41 HR1 Region From HIV-1 isolates From Enfuvirtide-Treated and Untreated Patients.
J Acquir Immune Defic Syndr. 2011;57 Suppl 3:S197-201.
PubMed Text format Related articles Abstract available

OGALHA C , Luz E, Sampaio E, Souza R, et al
A randomized, clinical trial to evaluate the impact of regular physical activity on the quality of life, body morphology and metabolic parameters of patients with AIDS in salvador, Brazil.
J Acquir Immune Defic Syndr. 2011;57 Suppl 3:S179-85.
PubMed Text format Related articles Abstract available

MOREIRA RI , Luz PM, Struchiner CJ, Morgado M, et al
Immune Status at Presentation for HIV Clinical Care in Rio de Janeiro and Baltimore.
J Acquir Immune Defic Syndr. 2011;57 Suppl 3:S171-8.
PubMed Text format Related articles Abstract available

DAMACENA GN , Szwarcwald CL, de Souza Junior PR, Dourado I, et al
Risk Factors Associated With HIV Prevalence Among Female Sex Workers in 10 Brazilian Cities.
J Acquir Immune Defic Syndr. 2011;57 Suppl 3:S144-52.
PubMed Text format Related articles Abstract available

SZWARCWALD CL , de Souza Junior PR, Damacena GN, Junior AB, et al
Analysis of Data Collected by RDS Among Sex Workers in 10 Brazilian Cities, 2009: Estimation of the Prevalence of HIV, Variance, and Design Effect.
J Acquir Immune Defic Syndr. 2011;57 Suppl 3:S129-35.
PubMed Text format Related articles Abstract available

BEYRER C , Baral S, Kerrigan D, El-Bassel N, et al
Expanding the Space: Inclusion of Most-at-Risk Populations in HIV Prevention, Treatment, and Care Services.
J Acquir Immune Defic Syndr. 2011;57 Suppl 2:S96-9.
PubMed Text format Related articles Abstract available

ATUN R , Bataringaya J
Building a Durable Response to HIV/AIDS: Implications for Health Systems.
J Acquir Immune Defic Syndr. 2011;57 Suppl 2:S91-5.
PubMed Text format Related articles Abstract available

RABKIN M , Nishtar S
Scaling Up Chronic Care Systems: Leveraging HIV Programs to Support Noncommunicable Disease Services.
J Acquir Immune Defic Syndr. 2011;57 Suppl 2:S87-90.
PubMed Text format Related articles Abstract available

MCNAIRY ML , Melaku Z, Barker PM, Abrams EJ, et al
Leveraging Progress in Prevention of Mother-to-Child Transmission of HIV for Improved Maternal, Neonatal, and Child Health Services.
J Acquir Immune Defic Syndr. 2011;57 Suppl 2:S83-6.
PubMed Text format Related articles Abstract available

FREEDMAN LP
Integrating HIV and Maternal Health Services: Will Organizational Culture Clash Sow the Seeds of a New and Improved Implementation Practice?
J Acquir Immune Defic Syndr. 2011;57 Suppl 2:S80-2.
PubMed Text format Related articles Abstract available

GREPIN KA
Leveraging HIV Programs to Deliver an Integrated Package of Health Services: Some Words of Caution.
J Acquir Immune Defic Syndr. 2011;57 Suppl 2:S77-9.
PubMed Text format Related articles Abstract available

ATUN R , Pothapregada SK, Kwansah J, Degbotse D, et al
Critical Interactions Between the Global Fund-Supported HIV Programs and the Health System in Ghana.
J Acquir Immune Defic Syndr. 2011;57 Suppl 2:S72-6.
PubMed Text format Related articles Abstract available

EL-SADR WM , Gonsalves G, Mugyenyi P
No need for apologies.
J Acquir Immune Defic Syndr. 2011;57 Suppl 2:S68-71.
PubMed Text format Related articles Abstract available

HARRIES AD , Makombe SD, Libamba E, Schouten EJ, et al
Why Did the Scale-up of HIV Treatment Work?: A Case Example From Malawi.
J Acquir Immune Defic Syndr. 2011;57 Suppl 2:S64-7.
PubMed Text format Related articles Abstract available

DE COCK KM , El-Sadr WM, Ghebreyesus TA
Game Changers: Why Did the Scale-Up of HIV Treatment Work Despite Weak Health Systems?
J Acquir Immune Defic Syndr. 2011;57 Suppl 2:S61-3.
PubMed Text format Related articles Abstract available

KRUK ME
HIV and Health Systems: Research to Bridge the Divide.
J Acquir Immune Defic Syndr. 2011;57 Suppl 2:S120-3.
PubMed Text format Related articles Abstract available

RAO P , Gabre-Kidan T, Mubangizi DB, Sulzbach S, et al
Leveraging the Private Health Sector to Enhance HIV Service Delivery in Lower-Income Countries.
J Acquir Immune Defic Syndr. 2011;57 Suppl 2:S116-9.
PubMed Text format Related articles Abstract available

GORMLEY W , McCaffery J, Quain EE
Moving Forward on Human Resources for Health: Next Steps for Scaling Up Toward Universal Access to HIV/AIDS Prevention, Treatment, and Care.
J Acquir Immune Defic Syndr. 2011;57 Suppl 2:S113-5.
PubMed Text format Related articles Abstract available

RASSCHAERT F , Philips M, Van Leemput L, Assefa Y, et al
Tackling Health Workforce Shortages During Antiretroviral Treatment Scale-up-Experiences From Ethiopia and Malawi.
J Acquir Immune Defic Syndr. 2011;57 Suppl 2:S109-12.
PubMed Text format Related articles Abstract available

HOLMES CB , Atun R, Avila C, Blandford JM, et al
Expanding the Generation and Use of Economic and Financial Data to Improve HIV Program Planning and Efficiency: A Global Perspective.
J Acquir Immune Defic Syndr. 2011;57 Suppl 2:S104-8.
PubMed Text format Related articles Abstract available

AMOLE CD , Brisebois C, Essajee S, Koehler E, et al
Optimizing Antiretroviral Product Selection: A Sample Approach to Improving Patient Outcomes, Saving Money, and Scaling-up Health Services in Developing Countries.
J Acquir Immune Defic Syndr. 2011;57 Suppl 2:S100-3.
PubMed Text format Related articles Abstract available

GUIMARAES MD , Grinsztejn B, Melo VH, Rocha GM, et al
Anal HPV prevalence and associated factors among HIV-seropositive men under antiretroviral treatment in Brazil.
J Acquir Immune Defic Syndr. 2011;57 Suppl 3:S217-24.
PubMed Text format Related articles Abstract available

PINTO VM , Golub JE, Tancredi MV, Alencar RS, et al
Cervical cytology and histopathologic abnormalities in women living with AIDS in Sao Paulo, Brazil.
J Acquir Immune Defic Syndr. 2011;57 Suppl 3:S212-6.
PubMed Text format Related articles Abstract available

BERMUDEZ-AZA EH , Kerr LR, Kendall C, Pinho AA, et al
Antiretroviral drug resistance in a respondent-driven sample of HIV-infected men who have sex with men in Brazil.
J Acquir Immune Defic Syndr. 2011;57 Suppl 3:S186-92.
PubMed Text format Related articles Abstract available

MATIDA LH , Santos NJ, Ramos AN Jr, Gianna MC, et al
Eliminating vertical transmission of HIV in Sao Paulo, Brazil: progress and challenges.
J Acquir Immune Defic Syndr. 2011;57 Suppl 3:S164-70.
PubMed Text format Related articles Abstract available

SOUTO MELO AP , Machado CJ, Crosland Guimaraes MD
HIV testing in psychiatric patients in Brazil.
J Acquir Immune Defic Syndr. 2011;57 Suppl 3:S157-63.
PubMed Text format Related articles Abstract available

SALANI MOTA RM , Sansigolo Kerr LR, Kendall C, Pinho A, et al
Reliability of self-report of HIV status among men who have sex with men in Brazil.
J Acquir Immune Defic Syndr. 2011;57 Suppl 3:S153-6.
PubMed Text format Related articles Abstract available

TOLEDO L , Codeco CT, Bertoni N, Albuquerque E, et al
Putting respondent-driven sampling on the map: insights from Rio de Janeiro, Brazil.
J Acquir Immune Defic Syndr. 2011;57 Suppl 3:S136-43.
PubMed Text format Related articles Abstract available

MARTINS AN , Arruda MB, Aleixo AW, Pires AF, et al
Prevalence of etravirine-associated mutations in clinical samples with genotypic resistance to nevirapine and efavirenz in Brazilian clinics.
J Acquir Immune Defic Syndr. 2011;57 Suppl 3:S193-6.
PubMed Text format Related articles Abstract available

POSSAS C , Buchalla CM, Hearst N
Building AIDS research capacity in Brazil.
J Acquir Immune Defic Syndr. 2011;57 Suppl 3:S125-8.
PubMed Text format Related articles

EL-SADR WM , Rabkin M, Atun R, De Cock KM, et al
Bridging the divide.
J Acquir Immune Defic Syndr. 2011;57 Suppl 2:S59-60.
PubMed Text format Related articles

CAMERON D
Scale-up and continuation of antiretroviral therapy in South African treatment programs, 2005-2009.
J Acquir Immune Defic Syndr. 2011;57:e92.
PubMed Text format Related articles

July 2011

CHUNG AW , Navis M, Isitman G, Wren L, et al
Activation of NK cells by ADCC antibodies and HIV disease progression.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

GRADY BJ , Samuels DC, Robbins GK, Selph D, et al
Mitochondrial Genomics and CD4 T-cell Count Recovery after Antiretroviral Therapy Initiation in AIDS Clinical Trials Group Study 384.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

BUTLER SL , Valdez H, Westby M, Perros M, et al
Disease-Modifying Therapeutic Concepts for HIV in the Era of Highly Active Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

KHAMDUANG W , Jourdain G, Sirirungsi W, Layangool P, et al
The interrelated transmission of human immunodeficiency virus type 1 and cytomegalovirus during gestation and delivery in the offspring of HIV-infected mothers.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MICHELOUD D , Berenguer J, Guzman-Fulgencio M, Campos Y, et al
European mitochondrial DNA haplogroups and metabolic disorders in HIV/HCV coinfected patients on highly active antiretroviral therapy.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

DRYDEN-PETERSON S , Jayeoba O, Hughes MD, Jibril H, et al
Highly Active Antiretroviral Therapy versus Zidovudine for Prevention of Mother-to-Child Transmission in a Programmatic Setting, Botswana.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

A M , Jf P, S S, J G, et al
HIV Infection and Progression of Carotid and Coronary Atherosclerosis: The CARE Study.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

ELLIS GM , Huang S, Hitti J, Frenkel LM, et al
Selection of HIV Resistance associated with Antiretroviral Therapy (ART) Initiated due to Pregnancy and Suspended Postpartum.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

GOUNDER CR , Kufa T, Wada NI, Mngomezulu V, et al
Diagnostic Accuracy of a Urine Lipoarabinomannan Enzyme-Linked Immunosorbent Assay for Screening Ambulatory HIV-Infected Persons for TB.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

KOBLIN BA , Mansergh G, Frye V, Van Tieu H, et al
Condom use decision making in the context of hypothetical pre-exposure prophylaxis efficacy among substance-using men who have sex with men: Project MIX.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

OTWOMBE KN , Sikkema KJ, Dietrich J, de Bruyn G, et al
Willingness to participate in biomedical HIV prevention studies after the HVTN 503/Phambili trial: A survey conducted amongst adolescents in Soweto, South Africa.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

BARNABAS RV , Wasserheit JN, Huang Y, Janes H, et al
Impact of Herpes Simplex Virus Type 2 on HIV-1 Acquisition and Progression in an HIV Vaccine Trial (the Step Study).
J Acquir Immune Defic Syndr. 2011;57:238-244.
PubMed Text format Related articles Abstract available

LUYIRIKA E , Kikule E, Kamba M, Buyondo F, et al
Meeting the Challenges of Disability and HIV in East Africa.
J Acquir Immune Defic Syndr. 2011;57:e68-9.
PubMed Text format Related articles

NAKAMOTO BK , Valcour VG, Kallianpur K, Liang CY, et al
Impact of Cerebrovascular Disease on Cognitive Function in HIV-Infected Patients.
J Acquir Immune Defic Syndr. 2011;57:e66-8.
PubMed Text format Related articles

KERNEIS S , Desaint C, Brichler S, Rey D, et al
Long-Term Persistence of Humoral Immunity After Hepatitis A Vaccination in HIV-Infected Adults.
J Acquir Immune Defic Syndr. 2011;57:e63-e66.
PubMed Text format Related articles

SONG JY , Lee JS, Jeong HW, Choi HJ, et al
Comparison of HIV-Infected Patients' Characteristics and Clinical Outcomes Between Cohort-Dependent and Independent Patients: Korean HIV Cohort Study.
J Acquir Immune Defic Syndr. 2011;57:e61-3.
PubMed Text format Related articles

JARRIN I , Boval B, Mazeron MC, Simoneau G, et al
Can Serum Soluble CD23 OR CD30 Predict the Occurence of Lymphoma in HIV-Infected Patients?
J Acquir Immune Defic Syndr. 2011;57:e58-61.
PubMed Text format Related articles

KUNZ K , Reiche S, Dwai Y, Cordes C, et al
A Broad Spectrum of Functional HIV-Specific Memory B Cells in the Blood of Infected Individuals With High CD4+ T-Cell Counts.
J Acquir Immune Defic Syndr. 2011;57:e56-8.
PubMed Text format Related articles

TCHENDJOU PT , Koki PN, Eboko F, Malateste K, et al
Factors Associated With History of HIV Testing Among Pregnant Women and Their Partners in Cameroon: Baseline Data From a Behavioral Intervention Trial (ANRS 12127 Prenahtest).
J Acquir Immune Defic Syndr. 2011;57 Suppl 1:S9-S15.
PubMed Text format Related articles Abstract available

D'ALMEIDA C , Essi MJ, Camara M, Coriat B, et al
Access to second-line antiretroviral therapeutic regimens in low-resource settings: experiences from cameroon.
J Acquir Immune Defic Syndr. 2011;57 Suppl 1:S55-8.
PubMed Text format Related articles Abstract available

KONATE I , Traore L, Ouedraogo A, Sanon A, et al
Linking HIV Prevention and Care for Community Interventions Among High-Risk Women in Burkina Faso-The ARNS 1222 "Yerelon" Cohort.
J Acquir Immune Defic Syndr. 2011;57 Suppl 1:S50-4.
PubMed Text format Related articles Abstract available

PERRINE R , Kouanfack C, Cohen J, Marcellin F, et al
Adherence to Antiretroviral Treatment in HIV-Positive Patients in the Cameroon Context: Promoting the Use of Medication Reminder Methods.
J Acquir Immune Defic Syndr. 2011;57 Suppl 1:S40-3.
PubMed Text format Related articles Abstract available

MESSOU E , Kouakou M, Gabillard D, Gouesse P, et al
Medication Possession Ratio: Predicting and Decreasing Loss to Follow-Up in Antiretroviral Treatment Programs in Cote d'Ivoire.
J Acquir Immune Defic Syndr. 2011;57 Suppl 1:S34-9.
PubMed Text format Related articles Abstract available

COFFIE PA , Kanhon SK, Toure H, Ettiegne-Traore V, et al
Nevirapine for the Prevention of Mother-to-Child Transmission of HIV: A Nation-Wide Coverage Survey in Cote d'Ivoire.
J Acquir Immune Defic Syndr. 2011;57 Suppl 1:S3-8.
PubMed Text format Related articles Abstract available

SUZAN-MONTI M , Blanche J, Bile P, Koulla-Shiro S, et al
Individual and Structural Factors Associated With HIV Status Disclosure to Main Partner in Cameroon: ANRS 12-116 EVAL Survey, 2006-2007.
J Acquir Immune Defic Syndr. 2011;57 Suppl 1:S22-6.
PubMed Text format Related articles Abstract available

OGA MA , Ndondoki C, Brou H, Salmon A, et al
Attitudes and Practices of Health Care Workers Toward Routine HIV Testing of Infants in Cote d'Ivoire: The PEDI-TEST ANRS 12165 Project.
J Acquir Immune Defic Syndr. 2011;57 Suppl 1:S16-21.
PubMed Text format Related articles Abstract available

BARRO M , Some J, Foulongne V, Diasso Y, et al
Short-term virological efficacy, immune reconstitution, tolerance, and adherence of once-daily dosing of didanosine, lamivudine, and efavirenz in HIV-1-infected African children: ANRS 12103 Burkiname.
J Acquir Immune Defic Syndr. 2011;57 Suppl 1:S44-9.
PubMed Text format Related articles Abstract available

MUWONGA J , Edidi S, Butel C, Vidal N, et al
Resistance to antiretroviral drugs in treated and drug-naive patients in the Democratic Republic of Congo.
J Acquir Immune Defic Syndr. 2011;57 Suppl 1:S27-33.
PubMed Text format Related articles Abstract available

June 2011

BYRD DA , Fellows RP, Morgello S, Franklin D, et al
Neurocognitive Impact of Substance Use in HIV Infection.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

EL-BASSEL N , Gilbert L, Wu E, Witte SS, et al
Couple-based HIV prevention for low-income drug users from New York City: A randomized controlled trial to reduce dual risks.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

ZHAO Y , Mu W, Harwell J, Zhou H, et al
Drug Resistance Profiles among HIV-1 Infected Children Experiencing Delayed Switch and 12-months Efficacy after Using Second-line Antiretroviral Therapy: An Observational Cohort Study in Rural China.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

ARMBRUSTER B , Helleringer S, Kohler HP, Mkandawire J, et al
Exploring the relative costs of contact tracing in increasing HIV case-finding in sub-Saharan countries: the case of Likoma Island (Malawi).
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

LAHUERTA M , Lima J, Elul B, Okamura M, et al
Patients enrolled in HIV care in Mozambique: Baseline characteristics and follow-up outcomes.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

TAN DH , Chan K, Raboud J, Cooper C, et al
Comparison of abacavir/lamivudine and tenofovir/emtricitabine among treatment-naive HIV-infected patients initiating therapy.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

SINGH A , Sunpath H, Green TN, Padayachi N, et al
Drug Resistance and Viral Tropism in HIV-1 Subtype C-Infected Patients in KwaZulu-Natal, South Africa: Implications for Future Treatment Options.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

SUKAPIROM K , Onlamoon N, Thepthai C, Polsrila K, et al
Performance Evaluation of the Alere PIMA CD4 Test for Monitoring HIV-Infected Individuals in Resource-Constrained Settings.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

FRIEDRICH D , Jalbert E, Dinges WL, Sidney J, et al
Vaccine-induced HIV-specific CD8+ T cells utilize preferential HLA alleles and target specific regions of HIV-1.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

CHIBWESHA CJ , Giganti MJ, Putta N, Chintu N, et al
Optimal Time on HAART for Prevention of Mother-to-Child Transmission of HIV.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MONROE AK , Dobs AS, Xu X, Palella FJ, et al
Sex Hormones, Insulin Resistance, and Diabetes Mellitus among Men with or at Risk for HIV Infection.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

DLAMINI JN , Hu Z, Ledwaba J, Morris L, et al
Genotypic Resistance at Viral Rebound among Patients Who Received Lopinavir/ritonavir- or Efavirenz-Based First Antiretroviral Therapy in South Africa.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

PADIAN NS , McCoy SI, Manian S, Wilson D, et al
Evaluation of Large-Scale Combination HIV Prevention Programs: Essential Issues.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

KASAMBA I , Sully E, Weiss HA, Baisley K, et al
Extra-spousal partnerships in a community in rural Uganda with high HIV prevalence: a cross-sectional population-based study using linked spousal data.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

ROSS AC , McComsey GA
Cardiovascular Disease Risk in Pediatric HIV: The Need for Population-Specific Guidelines.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles

MCMAHON JH , Wanke CA, Elliott JH, Skinner S, et al
Repeated assessments of food security predict CD4 change in the setting of antiretroviral therapy.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

SIGALOFF KC , Hamers RL, Wallis CL, Kityo C, et al
Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

WILLIAMS BG , Abdool Karim SS, Karim QA, Gouws E, et al
Epidemiological impact of tenofovir gel on the HIV epidemic in South Africa.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MAVEDZENGE SN , Weiss HA, Montgomery ET, Blanchard K, et al
Determinants of differential HIV incidence among women in three southern African locations.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

SABIN L , Tsoka M, Brooks M, Miller C, et al
Measuring vulnerability among orphans and vulnerable children in rural Malawi: validation study of the Child Status Index tool.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MILLETT GA , Ding H, Marks G, Iv WL, et al
Mistaken Assumptions and Missed Opportunities: Correlates of Undiagnosed HIV Infection among Black and Latino Men who have Sex with Men.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

WORODRIA1 W , Massinga-Loembe M, Mazakpwe D, Luzinda K, et al
Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

WRIGHT ST , Carr A, Woolley I, Giles M, et al
Cd4 Cell Responses to Combination Antiretroviral Therapy in Patients Starting Therapy at High Cd4 Cell Counts.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

JI B , M M, Fx Z, B A, et al
Hypertension and Isolated Office Hypertension in HIV-Infected Patients Determined By Ambulatory Blood Pressure Monitoring: Prevalence and Risk Factors.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

ESTRELLA MM , Parekh RS, Astor BC, Bolan R, et al
Chronic Kidney Disease and Estimates of Kidney Function in HIV Infection: a Cross-Sectional Study in the Multicenter AIDS Cohort Study.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

LYONS JL , Uno H, Ancuta P, Kamat A, et al
Plasma sCD14 is a Biomarker Associated with Impaired Neurocognitive Test Performance in Attention and Learning Domains in HIV Infection.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

RUBBO PA , Tuaillon E, Nagot N, Chentoufi AA, et al
HIV-1 Infection Impairs HSV-Specific CD4+ and CD8+ T Cell Response by Reducing Th1 Cytokines and CCR5 Ligand Secretion.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

AL A , Ja F, Pt K, Gk S, et al
Disparities in Antiretroviral Treatment: A Comparison of Behaviorally-HIV-Infected Youth and Adults in the HIV Research Network.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

CURTIS KA , Kennedy MS, Luckay A, Cong ME, et al
Delayed Maturation of Antibody Avidity but not Seroconversion in Rhesus Macaques Infected with SHIV during Oral Pre-Exposure Prophylaxis.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

TAMBUYZER L , Nijs S, Daems B, Picchio G, et al
Effect of Mutations at Position E138 in HIV-1 Reverse Transcriptase on Phenotypic Susceptibility and Virologic Response to Etravirine.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

WALLEY J , Kunutsor S, Evans M, Thoulass J, et al
Validation in Uganda of the New WHO Diagnostic Algorithm for Smear-Negative Pulmonary Tuberculosis in HIV Prevalent Settings: Validating a new WHO Diagnostic Algorithm for TB.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

CONNICK E , Bosch RJ, Aga E, Schlichtemeier R, et al
Augmented HIV-Specific Interferon-Gamma Responses, but Impaired Lymphoproliferation During Interruption of Antiretroviral Treatment Initiated in Primary HIV Infection.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

AKINSIKU OT , Bansal A, Sabbaj S, Heath SL, et al
Interleukin-2 Production by Polyfunctional HIV-1-Specific CD8 T-Cells is Associated with Enhanced Viral Suppression.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MWANGI M
Unsafe Sex Among HIV-Infected Adults in Kenya: Results of a Nationally-Representative Survey.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

LUFT LM , Beckthold B, Gill MJ
Increasing HIV Subtype Diversity in Canadian-Born Patients Living in Southern Alberta, Canada.
J Acquir Immune Defic Syndr. 2011;57:e27-9.
PubMed Text format Related articles

NDEMBI N , Iwamoto S, Ngansop C, Lemey P, et al
High Frequency of HIV-1 Dual Infections in Cameroon, West Central Africa.
J Acquir Immune Defic Syndr. 2011;57:e25-7.
PubMed Text format Related articles

GOETZ MB , Rimland D
Effect of Expanded HIV Testing Programs on the Status of Newly Diagnosed HIV-Infected Patients in Two Veterans Health Administration Facilities: 1999-2009.
J Acquir Immune Defic Syndr. 2011;57:e23-5.
PubMed Text format Related articles

SHANKARKUMAR A , Shankarkumar U, Ghosh K
CCR5 Chemokine Receptor Polymorphism in Patients With HIV-1 From Western India.
J Acquir Immune Defic Syndr. 2011;57:e21.
PubMed Text format Related articles

LIU FL , Yao YG, Li H, Zheng YT, et al
Human rights, ethics, and the protection of intravenous drug users are much improved in China.
J Acquir Immune Defic Syndr. 2011;57:e31-2.
PubMed Text format Related articles

May 2011

TRULLAS JC , Cofan F, Barril G, Martinez-Castelao A, et al
Outcome and Prognostic Factors in HIV-1-Infected Patients on Dialysis in the cART Era: a GESIDA/SEN Cohort Study.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MORIN SF , Kelly JA, Charlebois ED, Remien RH, et al
Responding to the National HIV/AIDS Strategy - Setting the Research Agenda.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles

XIUHONG L , B MJ, D JB, R RC, et al
CD4+ T-Cell Counts and Plasma HIV-1 RNA Levels Beyond 5 Years of Highly Active Antiretroviral Therapy (HAART).
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

JACOBSON DL , Williams P, Tassiopoulos K, Melvin A, et al
Clinical Management and Follow-up of Hypercholesterolemia Among Perinatally HIV-Infected Children Enrolled in the PACTG 219C Study.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

DOWDY DW , Geng EH, Christopoulos KA, Kahn JS, et al
Mortality Among Antiretroviral-Eligible Patients in an Urban Public Clinic.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

DAVE JA , Lambert EV, Phd MB, Phd SW, et al
Effect of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy on dysglycaemia and insulin sensitivity in South African HIV-infected patients.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

HEIDARI S , Mofenson L, Cotton MF, Marlink R, et al
Antiretroviral Drugs for Preventing Mother-to-Child Transmission of HIV: A Review of Potential Effects on HIV-Exposed but Uninfected Children.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

KRANTZ EM , Hullsiek KH, Okulicz JF, Weintrob AC, et al
Elevated CD8 Counts During HAART are Associated with HIV Virologic Treatment Failure.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

GUAY L
Decreasing HIV transmission through breastfeeding: Moving from evidence to practice.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles

DATE AA , Miller B
Antiretroviral therapy and tuberculosis: What's the connection and what's the way forward?
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles

G R , U R, P B, E P, et al
The cost of HIV disease in Northern Italy: the payer's perspective.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

VENKATESH KK , de Bruyn G, Mayer KH, Msc HC, et al
Changes in Sexual Risk Behavior Before and after HIV Seroconversion in Southern African Women Enrolled in A HIV Prevention Trial.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

VISHWANATHAN SA , Guenthner PC, Lin CY, Dobard C, et al
High Susceptibility to Repeated, Low-Dose, Vaginal SHIV Exposure Late in the Luteal Phase of the Menstrual Cycle of Pigtail Macaques.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

PALOMBI L , Luhanga R, Galluzzo C, Andreotti M, et al
Limited Risk of Drug Resistance after Discontinuation of Antiretroviral Prophylaxis for the Prevention of Breastfeeding Transmission of HIV.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

LEIBOWITZ AA , Mendes AC, Desmond K
Public Funding of HIV/AIDS Prevention, Treatment and Support in California.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

CIAMPA PJ , Burlison JR, Blevins M, Sidat M, et al
Improving Retention in the Early Infant Diagnosis of HIV Program in Rural Mozambique by Better Service Integration.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

KULKARNI H , Okulicz JF, Grandits G, Crum-Cianflone NF, et al
Early Post-Seroconversion CD4 Cell Counts Independently Predict CD4 Cell Count Recovery in HIV-1-Postive Subjects Receiving Antiretroviral Therapy.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

CHOI JY , Zhou J, Giles M, Broom J, et al
Predictors and Outcomes of HIV-Infected Antiretroviral-Naive Patients with Discordant Responses to Combination Antiretroviral Treatment in Asian and Australian Populations: Results from APHOD.
J Acquir Immune Defic Syndr. 2011;57:e13-e15.
PubMed Text format Related articles

BASTARD M , Fall MB, Laniece I, Taverne B, et al
Revisiting Long-Term Adherence to Highly Active Antiretroviral Therapy in Senegal Using Latent Class Analysis.
J Acquir Immune Defic Syndr. 2011;57:55-61.
PubMed Text format Related articles Abstract available

SARAVANAN S , Madhavan V, Murugavel KG, Balakrishnan P, et al
The Association between HIV-1 Subtype C Antiretroviral Resistance and HLA Prevalence in Southern India.
J Acquir Immune Defic Syndr. 2011;57:e17-9.
PubMed Text format Related articles

CHOI JY , Zhou J, Giles M, Broom J, et al
Predictors and outcomes of HIV-infected antiretroviral-naive patients with discordant responses to combination antiretroviral treatment in Asian and Australian populations: results from APHOD.
J Acquir Immune Defic Syndr. 2011;57:e13-5.
PubMed Text format Related articles

RALLON NI , Soriano V, Restrepo C, Garcia-Samaniego J, et al
HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
J Acquir Immune Defic Syndr. 2011;57:1-8.
PubMed Text format Related articles Abstract available

WOODS WJ , Binson D, Pollack LM
The evidence does not support a "no-door" policy.
J Acquir Immune Defic Syndr. 2011;57:e19-20.
PubMed Text format Related articles

CHARPENTIER C , Lambert-Niclot S, Larrouy L, Peytavin G, et al
Impact of Adding Enfuvirtide to the Predictive Value of the Darunavir Genotypic Resistance Score.
J Acquir Immune Defic Syndr. 2011;57:e15-e17.
PubMed Text format Related articles

April 2011

MARTINSON NA , Chaisson RE
Survival in XDR TB: Shifting the Curve and Shifting the Paradigm.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles

LOHSE N , Gerstoft J, Kronborg G, Larsen CS, et al
Comorbidity Acquired before HIV Diagnosis and Mortality in HIV-infected and Uninfected Persons: A Danish population-based cohort study.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles

TUCKER JD , Yang LG, Yang B, Zheng HP, et al
A Twin Response to Twin Epidemics: Integrated HIV/Syphilis Testing at STI clinics in South China.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles

ADAMS J , Nowels C, Corsi K, Long J, et al
HIV risk after release from prison: a qualitative study of former inmates.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles

YONG MK , Elliott JH, Woolley IJ, Hoy JF, et al
Low CD4 Count is Associated with an Increased Risk of Fragility Fracture in HIV-infected Patients.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles

WU ES , Metzger DS, Lynch KG, Douglas SD, et al
Association between Alcohol Use and HIV Viral Load.
J Acquir Immune Defic Syndr. 2011;56:e129-e130.
PubMed Text format Related articles

HAYASHI K , Montaner J, Kaplan K, Suwannawong P, et al
Low uptake of hepatitis C testing and high prevalence of risk behavior among HIV-positive injection drug users in Bangkok, Thailand.
J Acquir Immune Defic Syndr. 2011;56:e133-5.
PubMed Text format Related articles

BROWN LB , Miller WC, Kamanga G, Nyirenda N, et al
HIV partner notification is effective and feasible in sub-Saharan Africa: opportunities for HIV treatment and prevention.
J Acquir Immune Defic Syndr. 2011;56:437-42.
PubMed Text format Related articles Abstract available

IN'T VELD DH , Makatini Z, Mzileni O, Colebunders R, et al
Proposal to adjust the WHO clinical staging system.
J Acquir Immune Defic Syndr. 2011;56:e133.
PubMed Text format Related articles

POTTERAT JJ
Puzzling observations in a trial of HIV partner notification in sub-Saharan Africa.
J Acquir Immune Defic Syndr. 2011;56:381-3.
PubMed Text format Related articles

DURAND M , Sheehy O, Baril JG, Lelorier J, et al
Association between HIV infection, antiretroviral therapy and risk of acute myocardial infarction: a cohort and nested case-control study using Quebec's public health insurance database (RAMQ).
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

RHOADS MP , Lanigan J, Smith CJ, Lyall EG, et al
Effect of specific antiretroviral therapy (ART) drugs on lipid changes and the need for lipid management in children with HIV.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

TARIQ S , Townsend CL, Cortina-Borja M, Duong T, et al
Use of Zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

LIU KC , Mulindwa J, Giganti MJ, Putta NB, et al
Predictors of CD4 eligibility for antiretroviral therapy initiation among HIV-infected pregnant women in Lusaka, Zambia.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

REISNER SL , Falb KL, Mimiaga MJ
Early life traumatic stressors and the mediating role of post-traumatic stress disorder (PTSD) in incident HIV infection among U.S. men, comparisons by sexual orientation and race/ethnicity: Results from the National Epidemiologic Survey on Alcohol an
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MELCHJORSEN J , Risor MW, Sogaard OS, O'loughlin KL, et al
Tenofovir selectively regulates production of inflammatory cytokines and shifts the IL-12 / IL-10 balance in human primary cells.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

BARNABAS RV , Wasserheit JN, Huang Y, Janes H, et al
Impact of Herpes Simplex Virus Type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step Study).
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

ADEYEMI OM , Agniel D, French AL, Tien P, et al
Vitamin D deficiency in HIV-infected and un-infected women in the US.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

BREHM JH , Lalama CM, Hughes MD, Haubrich R, et al
Failure of Initial Therapy With Two Nucleosides and Efavirenz Is Not Associated With Early Emergence of Mutations in the C-Terminus of HIV-1 Reverse Transcriptase.
J Acquir Immune Defic Syndr. 2011;56:344-348.
PubMed Text format Related articles Abstract available

READ SW , Ciccone EJ, Mannon PJ, Yao MD, et al
The Effect of Intermittent IL-2 Therapy on CD4 T Cells in the Gut in HIV-1-Infected Patients.
J Acquir Immune Defic Syndr. 2011;56:340-343.
PubMed Text format Related articles Abstract available

FLYNN PM , Cunningham CK, Rudy B, Wilson CM, et al
Hepatitis B Vaccination in HIV-Infected Youth: A Randomized Trial of Three Regimens.
J Acquir Immune Defic Syndr. 2011;56:325-332.
PubMed Text format Related articles Abstract available

PISO RJ , Rothen M, Rothen JP, Stahl M, et al
Markers of bone turnover are elevated in patients with antiretroviral treatment independent of the substance used.
J Acquir Immune Defic Syndr. 2011;56:320-4.
PubMed Text format Related articles Abstract available

BATEGANYA MH , Stanaway J, Brentlinger PE, Magaret AS, et al
Predictors of Survival After a Diagnosis of Non-Hodgkin Lymphoma in a Resource-Limited Setting: A Retrospective Study on the Impact of HIV Infection and Its Treatment.
J Acquir Immune Defic Syndr. 2011;56:312-9.
PubMed Text format Related articles Abstract available

NELSON M , Yau S, Baber L, Myers J, et al
Combination antiretroviral therapy toxicities: a comparison between patients and health care professionals.
J Acquir Immune Defic Syndr. 2011;56:e120-1.
PubMed Text format Related articles

JOHNSON MO , Dilworth SE, Neilands TB
Partner Reports of Patients' HIV Treatment Adherence.
J Acquir Immune Defic Syndr. 2011;56:e117-8.
PubMed Text format Related articles

NDEMBI N , Ngansop C, Moudourou S, Tagny CT, et al
Can Oral Fluid Testing Be Used to Replace Blood-Based HIV Rapid Testing to Scale up Access to Diagnosis and Treatment in Cameroon?
J Acquir Immune Defic Syndr. 2011;56:e115-7.
PubMed Text format Related articles

NOZZA S , Galli L, Bigoloni A, Nicola G, et al
Durability and Safety of a Novel Salvage Therapy in R5-Tropic HIV-Infected Patients: Maraviroc, Raltegravir, Etravirine.
J Acquir Immune Defic Syndr. 2011;56:e113-5.
PubMed Text format Related articles

BOGOCH II , Andrews JR, Marty FM, Hohmann EL, et al
HIV-1 and 2009 H1N1 Influenza A in Adults.
J Acquir Immune Defic Syndr. 2011;56:e111-3.
PubMed Text format Related articles

KROWN SE
Cancer in resource-limited settings.
J Acquir Immune Defic Syndr. 2011;56:297-9.
PubMed Text format Related articles

SCHNEIDER JA , Laumann EO
Alternative explanations for negative findings in the community popular opinion leader multisite trial and recommendations for improvements of health interventions through social network analysis.
J Acquir Immune Defic Syndr. 2011;56:e119-20.
PubMed Text format Related articles

CORDERO OJ
Data on the interaction between prothymosin alpha and TLR4 may help to the design of new antiviral compounds.
J Acquir Immune Defic Syndr. 2011;56:e110-1.
PubMed Text format Related articles

March 2011

LAWN SD , Campbell L, Kaplan R, Boulle A, et al
Time to Initiation of Antiretroviral Therapy Among Patients With HIV-Associated Tuberculosis in Cape Town, South Africa.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

ARMSTRONG C , Liu E, Okuma J, Spiegelman D, et al
Dyslipidemia in an HIV-positive, antiretroviral treatment-naive population in Dar es Salaam, Tanzania.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

BRIAND N , Mandelbrot L, Blanche S, Tubiana R, et al
Previous antiretroviral therapy for prevention of mother-to-child transmission of HIV does not hamper the initial response to PI-based multitherapy during subsequent pregnancy.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

ELLIS CL , Ma ZM, Mann SK, Li CS, et al
Molecular Characterization of Stool Microbiota in HIV-Infected Subjects by Panbacterial and Order-Level 16S Ribosomal DNA (rDNA) Quantification and Correlations with Immune Activation.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

GOUNDER CR , Wada NI, Kensler C, Violari A, et al
Active Tuberculosis Case-Finding among Pregnant Women Presenting to Antenatal Clinics in Soweto, South Africa.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

KIEFFER MP , Nhlabatsi B, Mahdi M, Hoffman HJ, et al
Improved detection of incident HIV infection and uptake of PMTCT services in labor and delivery in a high HIV prevalence setting.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

ZHENG NN , McElrath MJ, Sow PS, Mesher A, et al
Association between Peripheral gammadelta T-cell Profile and Disease Progression in Individuals Infected with HIV-1 or HIV-2 in West Africa.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

TAHA TE , Li Q, Hoover DR, Mipando L, et al
Post-Exposure Prophylaxis of Breastfeeding HIV-Exposed Infants with Antiretroviral Drugs to Age 14 Weeks: Updated Efficacy Results of the PEPI-Malawi Trial.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

PETTIT AC , Jenkins CA, Stinnette SE, Rebeiro PF, et al
Tuberculosis Risk Before and After Highly Active Antiretroviral Therapy Initiation: Does HAART Increase the Short-term TB Risk in a Low Incidence TB Setting?
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MSC SN , Sabapathy K, Md CF, Md FV, et al
Incidence of tuberculosis in HIV-infected patients before and after starting antiretroviral therapy in 8 sub-Saharan African HIV programs.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

SIBERRY GK , Patel K, Van Dyke RB, Hazra R, et al
CD4+ Lymphocyte-Based Immunologic Outcomes of Perinatally HIV-Infected Children During Antiretroviral Therapy Interruption.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

BRANDT L , Benfield T, Mens H, Clausen LN, et al
Low level of regulatory T-cells and maintenance of balance between regulatory T-cells and TH17 cells in HIV-1-infected Elite Controllers.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

VAN DYKE RB , Patel K, Siberry GK, Burchett SK, et al
Antiretroviral Treatment of U.S. Children with Perinatally-Acquired HIV Infection: Temporal Changes in Therapy between 1991 and 2009 and Predictors of Immunologic and Virologic Outcomes.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

BRAITSTEIN P , Songok J, Vreeman R, Wools-Kaloustian K, et al
'Wamepotea' (They have become lost): Outcomes of HIV-positive and HIV-exposed children lost to follow-up from a large HIV treatment program in western Kenya.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

DELVAUX T , Samreth S, Barr-Dichiara M, Seguy N, et al
Linked Response for prevention, care and treatment of HIV/AIDS, STIs and reproductive health issues: Results after 18 months of implementation in five operational districts in Cambodia.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

BRAUNSTEIN SL , Umulisa MM, Veldhuijzen NJ, Kestelyn E, et al
HIV diagnosis, linkage to HIV care, and HIV risk behaviors among newly diagnosed HIV positive female sex workers in Kigali, Rwanda.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

TIEMESSEN CT , Paximadis M, Minevich G, Winchester R, et al
Natural killer cell responses to HIV-1 peptides are associated with more activating KIR genes and HLA-C genes of the C1 allotype.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

BUZON MJ , Wrin T, Codoner FM, Dalmau J, et al
Combined antiretroviral therapy and immune pressure lead to in vivo HIV-1 recombination with ancestral viral genomes.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

GINGO MR , Lucht L, Daly KR, Djawe K, et al
Serologic responses to Pneumocystis Proteins in Human Immunodeficiency Virus Patients With and Without Pneumocystis jirovecii Pneumonia.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

WHITMORE SK , Zhang X, Taylor AW, Blair JM, et al
Estimated Number of Infants Born to HIV-Infected Women in the United States and Five Dependent Areas, 2006.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

SIKKEMA KJ , Watt MH, Meade CS, Ranby KW, et al
Mental Health and HIV Sexual Risk Behavior among Patrons of Alcohol Serving Venues in Cape Town, South Africa.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

LAMBDIN BH , Micek MA, Koepsell TD, Hughes JP, et al
Patient Volume, Human Resource Levels and Attrition from HIV Treatment Programs in Central Mozambique.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

KLAUSNER JD , Serenata C, O'bra H, Mattson CL, et al
Scale-up and continuation of antiretroviral therapy in South african treatment programs, 2005-2009.
J Acquir Immune Defic Syndr. 2011;56:292-5.
PubMed Text format Related articles Abstract available

HALKITIS PN , Brockwell S, Siconolfi DE, Moeller RW, et al
Sexual behaviors of adolescent emerging and young adult men who have sex with men ages 13-29 in new york city.
J Acquir Immune Defic Syndr. 2011;56:285-91.
PubMed Text format Related articles Abstract available

MIDDELKOOP K , Bekker LG, Myer L, Johnson LF, et al
Antiretroviral Therapy and TB Notification Rates in a High HIV Prevalence South African Community.
J Acquir Immune Defic Syndr. 2011;56:263-269.
PubMed Text format Related articles Abstract available

HEMMERLING A , Cohen CR
Probiotics: The Potential for a Live Microbicide to Prevent HIV.
J Acquir Immune Defic Syndr. 2011;56:e98-e101.
PubMed Text format Related articles

CARR A
eGFR Slope and Tenofovir Nephrotoxicity.
J Acquir Immune Defic Syndr. 2011;56:e95-6.
PubMed Text format Related articles

MARSEILLE E , Shade SB, Myers J, Morin S, et al
The Cost-Effectiveness of HIV Prevention Interventions for HIV-Infected Patients Seen in Clinical Settings.
J Acquir Immune Defic Syndr. 2011;56:e87-94.
PubMed Text format Related articles Abstract available

CORNELL M , Grimsrud A, Boulle A, Myer L, et al
Retention among adults initiating antiretroviral therapy in South Africa: 2002-2007.
J Acquir Immune Defic Syndr. 2011;56:e102.
PubMed Text format Related articles

TASSIE JM , Chamla D, Souteyrand Y
Retention on antiretroviral therapy in national programs in low-income and middle-income countries.
J Acquir Immune Defic Syndr. 2011;56:e102-3.
PubMed Text format Related articles

COHEN MS
HIV Treatment as Prevention: In the Real World the Details Matter.
J Acquir Immune Defic Syndr. 2011;56:e101-2.
PubMed Text format Related articles

FINKELSTEIN R , Netherland J, Sylla L, Gourevitch MN, et al
Policy implications of integrating buprenorphine/naloxone treatment and HIV care.
J Acquir Immune Defic Syndr. 2011;56 Suppl 1:S98-S104.
PubMed Text format Related articles Abstract available

LUM PJ , Little S, Botsko M, Hersh D, et al
Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary care settings.
J Acquir Immune Defic Syndr. 2011;56 Suppl 1:S91-7.
PubMed Text format Related articles Abstract available

KORTHUIS PT , Fiellin DA, Fu R, Lum PJ, et al
Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine.
J Acquir Immune Defic Syndr. 2011;56 Suppl 1:S83-90.
PubMed Text format Related articles Abstract available

SCHACKMAN BR , Leff JA, Botsko M, Fiellin DA, et al
The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation.
J Acquir Immune Defic Syndr. 2011;56 Suppl 1:S76-82.
PubMed Text format Related articles Abstract available

WEISS L , Netherland J, Egan JE, Flanigan TP, et al
Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative.
J Acquir Immune Defic Syndr. 2011;56 Suppl 1:S68-75.
PubMed Text format Related articles Abstract available

VERGARA-RODRIGUEZ P , Tozzi MJ, Botsko M, Nandi V, et al
Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients.
J Acquir Immune Defic Syndr. 2011;56 Suppl 1:S62-7.
PubMed Text format Related articles Abstract available

SULLIVAN LE , Botsko M, Cunningham CO, O'Connor PG, et al
The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone.
J Acquir Immune Defic Syndr. 2011;56 Suppl 1:S54-61.
PubMed Text format Related articles Abstract available

EGAN JE , Netherland J, Gass J, Finkelstein R, et al
Patient perspectives on buprenorphine/naloxone treatment in the context of HIV care.
J Acquir Immune Defic Syndr. 2011;56 Suppl 1:S46-53.
PubMed Text format Related articles Abstract available

KORTHUIS PT , Tozzi MJ, Nandi V, Fiellin DA, et al
Improved quality of life for opioid-dependent patients receiving buprenorphine treatment in HIV clinics.
J Acquir Immune Defic Syndr. 2011;56 Suppl 1:S39-45.
PubMed Text format Related articles Abstract available

FIELLIN DA , Weiss L, Botsko M, Egan JE, et al
Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone.
J Acquir Immune Defic Syndr. 2011;56 Suppl 1:S33-8.
PubMed Text format Related articles Abstract available

ALTICE FL , Bruce RD, Lucas GM, Lum PJ, et al
HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.
J Acquir Immune Defic Syndr. 2011;56 Suppl 1:S22-32.
PubMed Text format Related articles Abstract available

CHAUDHRY AA , Botsko M, Weiss L, Egan JE, et al
Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care.
J Acquir Immune Defic Syndr. 2011;56 Suppl 1:S14-21.
PubMed Text format Related articles Abstract available

WEISS L , Egan JE, Botsko M, Netherland J, et al
The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine/naloxone and HIV treatment.
J Acquir Immune Defic Syndr. 2011;56 Suppl 1:S7-13.
PubMed Text format Related articles Abstract available

CHEEVER LW , Kresina TF, Cajina A, Lubran R, et al
A model federal collaborative to increase patient access to buprenorphine treatment in HIV primary care.
J Acquir Immune Defic Syndr. 2011;56 Suppl 1:S3-6.
PubMed Text format Related articles Abstract available

FRIEDLAND G , Vlahov D
Integration of buprenorphine for substance-abuse treatment by HIV care providers.
J Acquir Immune Defic Syndr. 2011;56 Suppl 1:S1-2.
PubMed Text format Related articles

SAYANA S , Javanbakht M, Weinstein M, Khanlou H, et al
Clinical impact and cost of laboratory monitoring need review even in resource-rich setting.
J Acquir Immune Defic Syndr. 2011;56:e97-8.
PubMed Text format Related articles

CICCONI P , Bini T, Barassi A, Casana M, et al
Detrimental Eeffect of Atazanavir Plasma Concentrations on Total Serum Bilirubin Levels in the Presence of UGT1A1 Polymorphisms.
J Acquir Immune Defic Syndr. 2011;56:e96-7.
PubMed Text format Related articles

CAMPBELL LJ , Hamzah L, Post FA
Is tenofovir-related renal toxicity incompletely reversible?
J Acquir Immune Defic Syndr. 2011;56:e95.
PubMed Text format Related articles

MONTANER J , Hogg R
Implications of the Henan Province report on the treatment as prevention debate.
J Acquir Immune Defic Syndr. 2011;56:e101.
PubMed Text format Related articles

February 2011

MORRISON CS , Chen PL, Nankya I, Rinaldi A, et al
Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

LIN NH , Smeaton LM, Giguel F, Novitsky V, et al
Prevalence and clinical associations of CXCR4-using HIV-1 among treatment-naive subtype C-infected women in Botswana.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

KRENTZ HB , Worthington H, Gill MJ
Adverse Health Effects for Individuals who Move between HIV Care Centres.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

BARONE MA , Ndede F, Li PS, Masson P, et al
The Shang Ring Device for Adult Male Circumcision: A Proof of Concept Study in Kenya.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

FILLER S , Berruti AA, Menzies N, Berzon R, et al
Characteristics of HIV Care and Treatment in PEPFAR-Supported Sites.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

KAJUBI P , Green EC, Hudes ES, Kamya MR, et al
Multiple sexual partnerships among poor urban dwellers in Kampala, Uganda.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

ESCOTE X , Miranda M, Veloso S, Domingo P, et al
Lipodystrophy and insulin resistance in combination antiretroviral treated HIV-1-infected patients: implication of resistin.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

LALEZARI J , Gathe J, Brinson C, Thompson M, et al
Safety, Efficacy, and Pharmacokinetics of TBR-652, a CCR5/CCR2 Antagonist, in HIV-1-Infected, Treatment-Experienced, CCR5 Antagonist-Naive Subjects.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

WATERS RC , Ostermann J, Reeves TD, Masnick MF, et al
A cost-effectiveness analysis of alternative HIV re-testing strategies in sub-Saharan Africa.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

GEIS S , Maboko L, Saathoff E, Hoffmann O, et al
Risk factors for HIV-1 infection in a longitudinal, prospective cohort of adults from the Mbeya Region, Tanzania.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

KVASNOVSKY CL , Cegielski JP, Erasmus R, Siwisa NO, et al
Extensively drug-resistant TB in Eastern Cape, South Africa: High Mortality in HIV negative and HIV positive patients.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

WANDERA B , Kamya MR, Castelnuovo B, Kiragga A, et al
Sexual behaviors over a 3-year period among individuals with advanced HIV/AIDS receiving antiretroviral therapy in an urban HIV clinic in Kampala, Uganda.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

HIV prevalence and risk practices among men who have sex with men in two South African cities.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

GERMAN D , Sifakis F, Maulsby C, Towe VL, et al
Persistently high prevalence and unrecognized HIV infection among men who have sex with men in Baltimore: the BESURE Study.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

BASTARD M , Koita Fall MB, Laniece I, Taverne B, et al
Revisiting long-term adherence to HAART in Senegal using latent class analysis.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

JENNESS SM , Neaigus A, Murrill CS, Wendel T, et al
Estimated HIV Incidence Among High-Risk Heterosexuals in New York City, 2007.
J Acquir Immune Defic Syndr. 2011;56:193-7.
PubMed Text format Related articles Abstract available

DEPATUREAUX A , Charpentier C, Leoz M, Unal G, et al
Impact of HIV-1 Group O Genetic Diversity on Genotypic Resistance Interpretation by Algorithms Designed for HIV-1 Group M.
J Acquir Immune Defic Syndr. 2011;56:139-145.
PubMed Text format Related articles Abstract available

BOUCHAUD O , Le Moing V, Simon F, Ngo Van P, et al
Similar Short-Term Efficacy of Antiretroviral Therapy in Patients Infected With HIV B and Non-B Subtype Strains in France.
J Acquir Immune Defic Syndr. 2011;56:e67-e69.
PubMed Text format Related articles

TORO PL , Schneider KL, Carter RJ, Abrams EJ, et al
Maternal and Infant Outcomes With Concurrent Treatment of Tuberculosis and HIV Infection in Pregnant Women.
J Acquir Immune Defic Syndr. 2011;56:e63-6.
PubMed Text format Related articles

SELLIER PO , Mario N, Rami A, Andreoli A, et al
Is Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Before Starting Sulfa Useful In HIV-Infected Male Patients Originating From Sub-Saharan Africa?
J Acquir Immune Defic Syndr. 2011;56:e60-3.
PubMed Text format Related articles

REXROTH K , Hare K, Kan VL
Rapid Oral HIV Screening: Expectations Revisited.
J Acquir Immune Defic Syndr. 2011;56:e59-60.
PubMed Text format Related articles

MANFREDI R
Hyperinflation of Quoted Co-Authors in Observational and Clinical Studies, Intercohort and Pooled Analyses, in the Field of HIV Disease. An Increasing Worrying Phenomenon for Its Clinical Consequences and the Degeneration of the Role of Authorship.
J Acquir Immune Defic Syndr. 2011;56:e56-8.
PubMed Text format Related articles

FALASCA F , Maida P, Montagna C, Antonelli L, et al
Expression of the mRNA Levels for MDR1, MRP1, MRP4, and MRP5 IN HIV Antiretroviral Naive Patients: Follow-up at 48 Weeks After the Beginning of Therapy.
J Acquir Immune Defic Syndr. 2011;56:e54-6.
PubMed Text format Related articles

COSSARINI F , Boeri E, Canducci F, Salpietro S, et al
Integrase and Fusion Inhibitors Transmitted Drug Resistance in Naive Patients With Recent Diagnosis of HIV-1 Infection.
J Acquir Immune Defic Syndr. 2011;56:e51-3.
PubMed Text format Related articles

MACENEANEY OJ , Connick E, Desouza CA
Effects of HIV-1 gp120 and Protease Inhibitors on Apoptotic Susceptibility of CD34+ Hematopoietic Progenitor Cells.
J Acquir Immune Defic Syndr. 2011;56:e49-50.
PubMed Text format Related articles

January 2011

MIROCHNICK M , Best BM, Stek AM, Capparelli EV, et al
Atazanavir Pharmacokinetics With and Without Tenofovir during Pregnancy.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

SAJADI MM , Guan Y, Devico AL, Seaman MS, et al
Correlation between circulating HIV-1 RNA and broad HIV-1 neutralizing antibody activity.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

RALLON NI , Soriano V, Restrepo C, Garcia-Samaniego J, et al
HCV-Specific T cell Responses in HIV/HCV coinfected patients on HAART are comparable to those observed in HCV-monoinfected individuals.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

SINGH KK , Gray PK, Wang Y, Fenton T, et al
HLA Alleles are Associated with Altered Risk for Disease Progression and Central Nervous System Impairment of HIV-Infected Children.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

SCHERRER AU , von Wyl V, Boni J, Yerly S, et al
Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

COOK RE , Ciampa PJ, Sidat M, Blevins M, et al
Predictors of successful early infant diagnosis of HIV in a rural district hospital in Zambezia, Mozambique.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

HAKRE S , Brett-Major DM, Singer D, O'connell RJ, et al
Medical Encounter Characteristics of HIV Seroconverters in the US Army and Air Force, 2000-2004.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

DRYDEN-PETERSON S , Shapiro RL, Hughes MD, Powis K, et al
Increased Risk of Severe Infant Anemia Following Exposure to Maternal HAART, Botswana.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

MONTSERRAT MD , Mercedes M, Maria-Jose S, Claudio RR, et al
Bacterial translocation in HIV-infected patients with HCV cirrhosis: Implication in haemodynamic alterations and mortality.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles

JAO J , Lo W, Toro PL, Wyatt C, et al
Factors Associated with Decreased Kidney Function in HIV-infected Adults Enrolled in the MTCT-Plus Initiative in Sub-Saharan Africa.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles

LI L , Tan S, Lu H, Lu L, et al
Combinations of 3-Hydroxyphthalic Anhydride-modified Ovalbumin with Antiretroviral Drug-based Microbicide Candidates Display Synergistic and Complementary Effects against HIV-1 Infection.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

FRANCO D , Liu W, Gardiner DF, Hahn BH, et al
CD40L-containing virus-like particle as a candidate HIV-1 vaccine targeting dendritic cells.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

WIGGILL TM , Mantina H, Willem P, Perner Y, et al
Changing Pattern of Lymphoma Subgroups at a Tertiary Academic Complex in a High Prevalence HIV setting - a South African Perspective.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

WAHL SM , Redford M, Christensen S, Mack W, et al
Systemic and Mucosal Differences in HIV Burden, Immune and Therapeutic Responses.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

VAN ZYL GU , van Mens TE, McIlleron H, Zeier M, et al
Low lopinavir plasma or hair concentrations explain second line protease inhibitor failures in a resource-limited setting.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

BRAUN M , Kabue MM, McCollum ED, Ahmed S, et al
Inadequate Coordination of Maternal and Infant HIV Services Detrimentally Affects Early Infant Diagnosis Outcomes in Lilongwe, Malawi.
J Acquir Immune Defic Syndr. 2011.
PubMed Text format Related articles Abstract available

ARNSTEN JH , Litwin AH, Berg KM
Effect of directly observed therapy for highly active antiretroviral therapy on virologic, immunologic, and adherence outcomes: a meta-analysis and systematic review.
J Acquir Immune Defic Syndr. 2011;56:e33-4.
PubMed Text format Related articles

KOON HB , Fingleton B, Lee JY, Geyer JT, et al
Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma.
J Acquir Immune Defic Syndr. 2011;56:64-8.
PubMed Text format Related articles Abstract available

December 2010

YI T , Cocohoba J, Cohen M, Anastos K, et al
The Impact of the AIDS Drug Assistance Program (ADAP) on Use of Highly Active Antiretroviral and Antihypertensive Therapy among HIV-Infected Women.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

CATTAMANCHI A , Smith R, Steingart KR, Metcalfe JZ, et al
Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals - A systematic review and meta-analysis.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

FINK VI , Shepherd BE, Cesar C, Krolewiecki A, et al
Cancer in HIV-infected Persons from the Caribbean, Central and South America.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

PADIAN NS , Holmes CB, McCoy SI, Lyerla R, et al
Implementation Science for PEPFAR.
J Acquir Immune Defic Syndr. 2010.
PubMed Text format Related articles Abstract available

EL-BASSEL N , Gilbert L, Witte S, Wu E, et al
Couple-Based HIV Prevention in the United States: Advantages, Gaps, and Future Directions.
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S98-S101.
PubMed Text format Related articles Abstract available

CHIASSON MA , Hirshfield S, Rietmeijer C
HIV Prevention and Care in the Digital Age.
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S94-7.
PubMed Text format Related articles Abstract available

OPERARIO D , Nemoto T
HIV in Transgender Communities: Syndemic Dynamics and a Need for Multicomponent Interventions.
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S91-3.
PubMed Text format Related articles Abstract available

WOODS WJ , Euren J, Pollack LM, Binson D, et al
HIV Prevention in Gay Bathhouses and Sex Clubs Across the United States.
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S88-90.
PubMed Text format Related articles Abstract available

CRAWFORD ND , Vlahov D
Progress in HIV Reduction and Prevention Among Injection and Noninjection Drug Users.
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S84-7.
PubMed Text format Related articles Abstract available

FLANIGAN TP , Zaller N, Beckwith CG, Bazerman LB, et al
Testing for HIV, Sexually Transmitted Infections, and Viral Hepatitis in Jails: Still a Missed Opportunity for Public Health and HIV Prevention.
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S78-83.
PubMed Text format Related articles Abstract available

SAFREN SA , Reisner SL, Herrick A, Mimiaga MJ, et al
Mental Health and HIV Risk in Men Who Have Sex With Men.
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S74-7.
PubMed Text format Related articles Abstract available

LANSKY A , Brooks JT, Dinenno E, Heffelfinger J, et al
Epidemiology of HIV in the United States.
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S64-8.
PubMed Text format Related articles Abstract available

EL-SADR WM , Mayer KH, Adimora AA
The HIV Epidemic in the United States: A Time for Action.
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S63.
PubMed Text format Related articles

COLLINS C , Diallo DD
A Prevention Response That Fits America's Epidemic: Community Perspectives on the Status of HIV Prevention in the United States.
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S148-50.
PubMed Text format Related articles Abstract available

DONNELL D , Hughes JP, Fleming TR
Challenges in the Design of HIV Prevention Trials in the United States.
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S136-40.
PubMed Text format Related articles Abstract available

ADIMORA AA , Auerbach JD
Structural Interventions for HIV Prevention in the United States.
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S132-5.
PubMed Text format Related articles Abstract available

FUCHS JD , Sobieszczyk ME, Hammer SM, Buchbinder SP, et al
Lessons Drawn From Recent HIV Vaccine Efficacy Trials.
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S128-31.
PubMed Text format Related articles Abstract available

MAYER KH , Venkatesh KK
Chemoprophylaxis for HIV Prevention: New Opportunities and New Questions.
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S122-7.
PubMed Text format Related articles Abstract available

EL-SADR WM , Affrunti M, Gamble T, Zerbe A, et al
Antiretroviral Therapy: A Promising HIV Prevention Strategy?
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S116-21.
PubMed Text format Related articles Abstract available

FISHER JD , Smith LR, Lenz EM
Secondary Prevention of HIV in the United States: Past, Current, and Future Perspectives.
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S106-15.
PubMed Text format Related articles Abstract available

BRANSON BM
The Future of HIV Testing.
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S102-5.
PubMed Text format Related articles Abstract available

KISSINGER P , Mena L, Levison J, Clark RA, et al
A RANDOMIZED TREATMENT TRIAL: SINGLE VERSUS 7 DAY DOSE OF METRONIDAZOLE FOR THE TREATMENT OF TRICHOMONAS VAGINALIS AMONG HIV-INFECTED WOMEN.
J Acquir Immune Defic Syndr. 2010;55:565-571.
PubMed Text format Related articles Abstract available

HODDER SL , Justman J, Haley DF, Adimora AA, et al
Challenges of a hidden epidemic: HIV prevention among women in the United States.
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S69-73.
PubMed Text format Related articles Abstract available

MILLETT GA , Crowley JS, Koh H, Valdiserri RO, et al
A way forward: the National HIV/AIDS Strategy and reducing HIV incidence in the United States.
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S144-7.
PubMed Text format Related articles Abstract available

RABKIN M , El-Sadr WM, Mugyenyi P, Ramatlapeng MK, et al
Lessons from Africa.
J Acquir Immune Defic Syndr. 2010;55 Suppl 2:S141-3.
PubMed Text format Related articles Abstract available

October 2010

LU W , Zeng G, Luo J, Duo S, et al
HIV transmission risk among serodiscordant couples: a retrospective study of former plasma donors in Henan, China.
J Acquir Immune Defic Syndr. 2010;55:232-238.
PubMed Text format Related articles Abstract available

September 2010

UNDERHILL K , Operario D, Skeer M, Mimiaga M, et al
Packaging PrEP to Prevent HIV: An Integrated Framework to Plan for Pre-Exposure Prophylaxis Implementation in Clinical Practice.
J Acquir Immune Defic Syndr. 2010;55:8-13.
PubMed Text format Related articles Abstract available

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from Boehringer Ingelheim.

Amedeo is a Flying Publisher website.
Design: